Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)

Endocrine-Related Cancer

Volumn 14, Issue 3, 2007, Pages 755-767

  Cust, Anne E ^a,b,c   Kaaks, Rudolf ^a,d   Friedenreich, Christine ^a,e   Bonnet, Fabrice ^c,f   Laville, Martine ^c,f   Tjønneland, Anne ^g   Olsen, Anja ^g   Overvad, Kim ^h   Jakobsen, Marianne Uhre ^h   Chajès, Véronique ^f   Clavel Chapelon, Françoise ^f   Boutron Ruault, Marie Christine ^f   Linseisen, Jakob ^d   Lukanova, Annekatrin ^d   Boeing, Heiner ⁱ   Pischon, Tobias ⁱ   Trichopoulou, Antonia ^j   Christina, Bamia ^j   Trichopoulos, Dimitrios ^j,k   Palli, Domenico ^l   Berrino, Franco ^m   Panico, Salvatore ⁿ   Tumino, Rosario ^o   Sacerdote, Carlotta ^p   Gram, Inger Torhild ^q   Lund, Eiliv ^q   Quiros J R ^r   Travier, Noémie ^s   Martínez García, Carmen ^t   Larrañaga, Nerea ^u   Chirlaque, María Dolores ^v   Ardanaz, Eva ^w   Berglund, Göran ^x   Lundin, Eva ^y   Bueno De Mesquita, H Bas ^z   Van Duijnhoven, Fränzel J B ^z   Peeters, Petra H M ^aa   Bingham, Sheila ^ab,ac   Khaw, Kay Tee ^ac   Allen, Naomi ^ad   Key, Tim ^ad   Ferrari, Pietro ^a   Rinaldi, Sabina ^a   Slimani, Nadia ^a   Riboli, Eho ^ae   more..

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITÉ LYON 1   (France)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e Alberta Cancer Board   (Canada)

^f INSERM   (France)

^g INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^h AARHUS UNIVERSITY HOSPITAL   (Denmark)

ⁱ GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^j UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^k HELLENIC HEALTH FOUNDATION   (Greece)

^l CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^m NATIONAL CANCER INSTITUTE   (Italy)

ⁿ UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^o CIVILE M P AREZZO HOSPITAL   (Italy)

^p CPO Piemonte   (Italy)

^q UNIVERSITY OF TROMSØ   (Norway)

^r Public Health and Health Planning Directorate   (Spain)

^s CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^t ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^u Basque Government   (Spain)

^v DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^w INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^x LUND UNIVERSITY HOSPITAL   (Sweden)

^y UMEÅ UNIVERSITY   (Sweden)

^z NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^aa UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^ab UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ac UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ad UNIVERSITY OF OXFORD   (United Kingdom)

^ae IMPERIAL COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CANCER RISK; CARCINOGENESIS; CHOLESTEROL BLOOD LEVEL; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEALTH CARE ORGANIZATION; HORMONE SUBSTITUTION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; OBESITY; ORAL CONTRACEPTION; POSTMENOPAUSE; PREMENOPAUSE; PROTEIN FUNCTION; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 35948940140     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/ERC-07-0132     Document Type: Article

References (52)

1. Ahmed M, Gannon MC & Nuttall FQ 1976 Postprandial plasma glucose, insulin, glucagon and triglyceride responses to a standard diet in normal subjects. Diabetologia 12 61-67.
2. Alberti KG, Zimmet P & Shaw J 2006 Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabetic Medicine 23 469-480.
3. Anderson KE, Anderson E, Mink PJ, Hong CP, Kushi LH, Sellers TA, Lazovich D & Folsom AR 2001 Diabetes and endometrial cancer in the Iowa women's health study. Cancer Epidemiology, Biomarkers and Prevention 10 611-616.
4. Bergman RN & Mittelman SD 1998 Central role of the adipocyte in insulin resistance. Journal of Basic and Clinical Physiology and Pharmacology 9 205-221.
5. Boyanton BL Jr & Blick KE 2002 Stability studies of twenty-four analytes in human plasma and serum. Clinical Chemistry 48 2242-2247.
6. Bradley DD, Wingerd J, Petitti DB, Krauss RM & Ramcharan S 1978 Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins. New England Journal of Medicine 299 17-20.
7. Calle EE & Kaaks R 2004 Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nature Reviews. Cancer 4 579-591.
8. Clark ML, Humphreys SM & Frayn KN 1990 Stability of plasma glucose during storage. Annals of Clinical Biochemistry 27 373-377.
9. Cust AE, Allen NE, Rinaldi S, Dossus L, Friedenreich C, Olsen A, Tjonneland A, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC et al. 2007a Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European prospective investigation into cancer and nutrition. International Journal of Cancer 120 2656-2664.
10. Cust AE, Kaaks R, Friedenreich C, Bonnet F, Laville M, Lukanova A, Rinaldi S, Dossus L, Slimani N, Lundin E et al. 2007b Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women. Journal of Clinical Endocrinology and Metabolism 92 255-263.
11. Dandona P, Thusu K, Cook S, Snyder B, Makowski J, Armstrong D & Nicotera T 1996 Oxidative damage to DNA in diabetes mellitus. Lancet 347 444-445.
12. Demacker PN, Schade RW, Jansen RT & Van't Laar A 1982 Intra-individual variation of serum cholesterol, triglycerides and high density lipoprotein cholesterol in normal humans. Atherosclerosis 45 259-266.
13. Elgee NJ 1970 Medical aspects of oral contraceptives. Annals of Internal Medicine 72 409-418.
14. Friedewald WT, Levy RI & Fredrickson DS 1972 Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 18 499-502.
15. Furberg AS & Thune I 2003 Metabolic abnormalities (hypertension, hyperglycemia and overweight), lifestyle (high energy intake and physical inactivity) and endometrial cancer risk in a Norwegian cohort. International Journal of Cancer 104 669-676.
16. Furberg AS, Jasienska G, Bjurstam N, Torjesen PA, Emaus A, Lipson SF, Ellison PT & Thune I 2005 Metabolic and hormonal profiles: HDL cholesterol as a plausible biomarker of breast cancer risk. The Norwegian EBBA Study. Cancer Epidemiology, Biomarkers and Prevention 14 33-40.
17. Goldman NA, Katz EB, Glenn AS, Weldon RH, Jones JG, Lynch U, Fezzari MJ, Runowicz CD, Goldberg GL & Charron MJ 2006 GLUT1 and GLUT8 in endometrium and endometrial adenocarcinoma. Modern Pathology 19 1429-1436.
18. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr et al. 2005 Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 2735-2752.
19. Haffner SM & Valdez RA 1995 Endogenous sex hormones: impact on lipids, lipoproteins, and insulin. American Journal of Medicine 98 40S-47S.
20. Haftenberger M, Schuit AJ, Tormo MJ, Boeing H, Wareham N, Bueno-de-Mesquita HB, Kumle M, Hjartaker A, Chirlaque MD, Ardanaz E et al. 2002a Physical activity of subjects aged 50-64 years involved in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutrition 5 1163-1176.
21. Haftenberger M, Lahmann PH, Panico S, Gonzalez CA, Seidell JC, Boeing H, Giurdanella MC, Krogh V, Bueno-de-Mesquita HB, Peeters PH et al. 2002b Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutrition 5 1147-1162.
22. Hankinson SE, London SJ, Chute CG, Barbieri RL, Jones L, Kaplan LA, Sacks FM & Stampfer MJ 1989 Effect of transport conditions on the stability of biochemical markers in blood. Clinical Chemistry 35 2313-2316.
23. Hiatt RA & Fireman BH 1986 Serum cholesterol and the incidence of cancer in a large cohort. Journal of Chronic Diseases 39 861-870.
24. Kaaks R & Lukanova A 2001 Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proceedings of the Nutrition Society 60 91-106.
25. Kaaks R, Lukanova A & Kurzer MS 2002 Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiology, Biomarkers and Prevention 11 1531-1543.
26. Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, Secreto G, Amiano P, Bingham S, Boeing H et al. 2005 Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). Journal of National Cancer Institute 97 755-765.
27. Key TJ & Pike MC 1988 The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. British Journal of Cancer 57 205-212.
28. Kronenberg F, Lobentanz EM, Konig P, Utermann G & Dieplinger H 1994 Effect of sample storage on the measurement of lipoprotein[a], apolipoproteins B and A-IV, total and high density lipoprotein cholesterol and triglycerides. Journal of Lipid Research 35 1318-1328.
29. Larsson SC, Friberg E & Wolk A 2007 Carbohydrate intake, glycemic index and glycemic load in relation to risk of endometrial cancer: A prospective study of Swedish women. International Journal of Cancer 120 1103-1107.
30. Law MR & Thompson SG 1991 Low serum cholesterol and the risk of cancer: an analysis of the published prospective studies. Cancer Causes and Control 2 253-261.
31. Levran D, Modan M, Menczer J & Dulitzy M 1984 Increased rate of glucose intolerance in endometrial cancer - a community-based study. Gynecologic and Obstetric Investigation 18 190-193.
32. Lukanova A, Zeleniuch-Jacquotte A, Lundin E, Micheli A, Arslan AA, Rinaldi S, Muti P, Lenner P, Koenig KL, Biessy C et al. 2004 Prediagnostic levels of C-peptide, IGF-I, IGFBP-1, -2 and -3 and risk of endometrial cancer. International Journal of Cancer 108 262-268.
33. Medina RA, Meneses AM, Vera JC, Guzman C, Nualart F, Rodriguez F, de los Angeles Garcia M, Kato S, Espinoza N, Monso C et al. 2004 Differential regulation of glucose transporter expression by estrogen and progesterone in Ishikawa endometrial cancer cells. Journal of Endocrinology 182 467-478.
34. Muti P, Quattrin T, Grant BJ, Krogh V, Micheli A, Schunemann HJ, Ram M, Freudenheim JL, Sieri S, Trevisan M et al. 2002 Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiology, Biomarkers and Prevention 11 1361-1368.
35. Nagamani M & Stuart CA 1998 Specific binding and growth-promoting activity of insulin in endometrial cancer cells in culture. American Journal of Obstetrics and Gynaecology 179 6-12.
36. Riboli E & Kaaks R 1997 The EPIC Project: rationale and study design. Investigation into Cancer and Nutrition. International Journal of Epidemiology 26 S6-S14.
37. Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, Charrondiere UR, Hemon B, Casagrande C, Vignat J et al. 2002 European prospective investigation into cancer and nutrition (EPIC): study populations and data collection. Public Health Nutrition 5 1113-1124.
38. Richardson DB 2004 An incidence density sampling program for nested case-control analyses. Occupational and Environmental Medicine 61 e59.
39. Rifai N, Merrill JR & Holly RG 1990 Postprandial effect of a high fat meal on plasma lipid, lipoprotein cholesterol and apolipoprotein measurements. Annals of Clinical Biochemistry 27 489-493.
40. Rutanen EM, Stenman S, Blum W, Karkkainen T, Lehtovirta P & Stenman UH 1993 Relationship between carbohydrate metabolism and serum insulin-like growth factor system in postmenopausal women: comparison of endometrial cancer patients with healthy controls. Journal of Clinical Endocrinology and Metabolism 77 199-204.
41. Salazar-Martinez E, Lazcano-Ponce EC, Lira-Lira GG, Escudero-De los Rios P, Salmeron-Castro J, Larrea F & Hernandez-Avila M 2000 Case-control study of diabetes, obesity, physical activity and risk of endometrial cancer among Mexican women. Cancer Causes and Control 11 707-711.
42. Sherman ME 2000 Theories of endometrial carcinogenesis: a multidisciplinary approach. Modern Pathology 13 295-308.
43. Shibata K, Kajiyama H, Ino K, Nawa A, Nomura S, Mizutani S & Kikkawa F 2007 P-LAP/IRAP-induced cell proliferation and glucose uptake in endometrial carcinoma cells via insulin receptor signaling. BMC Cancer 7 15.
44. Shih WJ, Bachorik PS, Haga JA, Myers GL & Stein EA 2000 Estimating the long-term effects of storage at -70°C on cholesterol, triglyceride, and HDL-cholesterol measurements in stored sera. Clinical Chemistry 46 351-364.
45. Shoff SM & Newcomb PA 1998 Diabetes, body size, and risk of endometrial cancer. American Journal of Epidemiology 148 234-240.
46. Shumak SL & Campbell NR 1993 Intraindividual variation in lipid and lipoprotein levels. Canadian Medical Association Journal 149 843-844.
47. Sun Y 1990 Free radicals, antioxidant enzymes, and carcinogenesis. Free Radical Biology & Medicine 8 583-599.
48. Swanson CA, Potischman N, Barrett RJ, Berman ML, Mortel R, Twiggs LB, Wilbanks GD, Hoover RN & Brinton LA 1994 Endometrial cancer risk in relation to serum lipids and lipoprotein levels. Cancer Epidemiology, Biomarkers and Prevention 3 575-581.
49. Wallace RB, Hoover J, Barrett-Connor E, Rifkind BM, Hunninghake DB, Mackenthun A & Heiss G 1979 Altered plasma lipid and lipoprotein levels associated with oral contraceptive and oestrogen use. Report from the Medications Working Group of the Lipid Research Clinics Program. Lancet 2 112-115.
50. Weiderpass E, Persson I, Adami HO, Magnusson C, Lindgren A & Baron JA 2000 Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes and Control 11 185-192.
51. Wilder LB, Bachorik PS, Finney CA, Moy TF & Becker DM 1995 The effect of fasting status on the determination of low-density and high-density lipoprotein cholesterol. American Journal of Medicine 99 374-377.
52. World Health Organization 2003 Pathology and genetics. Tumours of the breast and female genital organs. In World Health Organization Classification of Tumours, Eds FA Tavassoli & D Devilee. Lyon: IARC Press.